» Articles » PMID: 8706303

Risk Factors for Secondary Hyperparathyroidism in a Nursing Home Population

Overview
Specialty Endocrinology
Date 1996 Apr 1
PMID 8706303
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Secondary hyperparathyroidism may cause bone loss and structural deterioration of bone and may thus be a cause of fracture in the elderly. Vitamin D deficiency, renal impairment and medications are potential causes of hyperparathyroidism and may also directly predispose to fracture. We present the first findings of an ongoing study of hip fracture, vitamin D deficiency and hyperparathyroidism in a large Australian nursing home.

Design: Descriptive prevalence study.

Patients: Two hundred and fifty-one nursing home residents were eligible for inclusion. Informed consent and successful venepuncture were obtained for 99. Residents were of median age 83 years with interquartile range (IR) 77-89 years.

Measurements: 25-Hydroxyvitamin D (25OHD), intact parathyroid hormone (PTH), creatinine and biochemistry, demographic data and current medications.

Results: Fifty-two per cent of 99 subjects had 25OHD below the reference range of 28-165 nmol/l and 96.5% were below the reference range mean. Those with low 25OHD had lower plasma calcium corrected for albumin than those with normal 25OHD (medians 2.34 vs 2.41 mmol/l, 95% confidence interval for the difference between medians (CI) -0.10 to -0.04 mmol/l, P = 0.0001) and higher PTH (medians 5.8 vs 3.9 pmol/l, CI 0.10-2.6 pmol/l, P = 0.0360). Twenty-eight per cent of 97 residents had PTH above the upper reference range limit of 6.5 pmol/l. Residents receiving frusemide had higher PTH than other residents (medians 6.95 vs 3.45 pmol/l, CI 1.9-4.2 pmol/l, P < 0.0001). In linear modelling, the most important predictor of the natural logarithm of PTH was daily frusemide dose, adjusted R2 (Ra2) = 31.8%, F = 39.3, P < 0.001. Creatinine and the reciprocal of 25OHD were other significant predictors with the final Ra2 = 39.4%, F = 17.7, P < 0.001.

Conclusions: Vitamin D deficiency is a common risk factor for secondary hyperparathyroidism in nursing home residents despite a climate in which vitamin D nutrition is thought to be ample. However, the daily frusemide dose is a more important predictor of PTH in this population.

Citing Articles

Vitamin D deficiency in elderly: Risk factors and drugs impact on vitamin D status.

Kweder H, Eidi H Avicenna J Med. 2018; 8(4):139-146.

PMID: 30319955 PMC: 6178567. DOI: 10.4103/ajm.AJM_20_18.


Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.

Elias R, Moyses R Int Urol Nephrol. 2017; 49(10):1815-1821.

PMID: 28695313 DOI: 10.1007/s11255-017-1650-7.


Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss.

Kubota T, Namba N, Kurotobi S, Kogaki S, Hirai H, Kitaoka T Clin Pediatr Endocrinol. 2014; 15(3):101-7.

PMID: 24790329 PMC: 4004841. DOI: 10.1297/cpe.15.101.


Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes.

Rolland Y, de Souto Barreto P, Abellan van Kan G, Annweiler C, Beauchet O, Bischoff-Ferrari H J Nutr Health Aging. 2013; 17(4):402-12.

PMID: 23538667 DOI: 10.1007/s12603-013-0007-x.


Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol.

Isakova T, Xie H, Barchi-Chung A, Smith K, Sowden N, Epstein M Clin J Am Soc Nephrol. 2012; 7(5):820-8.

PMID: 22383746 PMC: 3338283. DOI: 10.2215/CJN.11721111.